(Q37958249)

25 August 2017

title

Vitiligo as an inflammatory skin disorder: a therapeutic perspective (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

Alain Taïeb

1

1 reference

25 August 2017

publication date

7 December 2011

1 reference

Pigment Cell & Melanoma Research

25 August 2017

published in

1 reference

25 August 2017

volume

25

1 reference

25 August 2017

issue

1

1 reference

25 August 2017

page(s)

9-13

1 reference

Comprehensive association analysis of candidate genes for generalized vitiligo supports XBP1, FOXP3, and TSLP.

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Epicutaneous aeroallergen sensitization in atopic dermatitis infants - determining the role of epidermal barrier impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

The IL-23/Th17 axis in the immunopathogenesis of psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Koebner's phenomenon in vitiligo: European position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Hypothesis: symmetrical cutaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Psoriasis is associated with increased beta-defensin genomic copy number

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

NALP1 in vitiligo-associated multiple autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Common variants in FOXP1 are associated with generalized vitiligo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Reduced skin homing by functional Treg in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

4-Tertiary butyl phenol exposure sensitizes human melanocytes to dendritic cell-mediated killing: relevance to vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Tumor-specific Th17-polarized cells eradicate large established melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Childhood- and later-onset vitiligo have diverse epidemiologic and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Clinical practice. Vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Melanocyte-specific cell mediated immune response in vitiliginous Smyth line chickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Th17 cells and activated dendritic cells are increased in vitiligo lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-148X.2011.00939.X

10.1111/J.1755-148X.2011.00939.X

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference